Business Context and Reporting Period
Company: Texas Instruments Incorporated (TI)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: TI designs and manufactures semiconductors, primarily analog and embedded processing products, sold to electronics designers and manufacturers globally. The company operates through two reportable segments: Analog and Embedded Processing, with remaining activities reported in "Other." TI's strategy focuses on maximizing long-term free cash flow per share through a business model built on manufacturing advantages, a broad product portfolio, market channel reach, and product diversity.
Key Financial Metrics
| Metric (in millions, except per share) | 2024 | 2023 |
|---|---|---|
| Revenue | $15,641 | $17,519 |
| Gross Profit | $9,094 | $11,019 |
| Gross Margin | 58.1% | 62.9% |
| Operating Profit | $5,465 | $7,331 |
| Operating Margin | 34.9% | 41.8% |
| Net Income | $4,799 | $6,510 |
| Diluted EPS | $5.20 | $7.07 |
| Cash Flow from Operations | $6,318 | $6,420 |
| Free Cash Flow (Non-GAAP) | $1,498 | $1,349 |
| Capital Expenditures | $4,820 | $5,071 |
| Total Debt (Long-term + Current) | $13,596 | $11,223 |
| Cash and Short-term Investments | $7,580 | $8,575 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 10.7% to $15.64 billion, driven by lower demand in both Analog (-7%) and Embedded Processing (-25%) segments.
- Margin Compression: Gross margin fell to 58.1% from 62.9%, primarily due to lower revenue volumes and higher manufacturing costs associated with planned capacity expansions (300mm wafer fabs).
- Segment Performance:
- Analog: Revenue of $12.16 billion; operating profit declined 21% to $4.61 billion.
- Embedded Processing: Revenue of $2.53 billion; operating profit declined 65% to $352 million due to lower revenue and gross profit.
- Other: Revenue of $947 million; operating profit increased slightly to $505 million, aided by a $124 million credit from restructuring/other items (gain on property sale).
- Debt Issuance: Interest and debt expense increased $155 million to $508 million following the issuance of $3.00 billion in new long-term debt in February 2024.
- Inventory Build: Inventory increased $528 million to $4.53 billion, with days of inventory rising to 241 from 219, reflecting a strategy to build ahead of demand.
Guidance, Outlook, and Risks
Management Commentary & Strategy: TI continues to prioritize long-term free cash flow per share growth. The company is executing a significant capital investment plan to expand 300mm wafer fabrication capacity in Sherman, Texas, and Lehi, Utah. Management expects capital expenditures to remain at elevated levels to support future revenue growth. The company received a $588 million cash benefit in 2024 from the U.S. CHIPS and Science Act investment tax credit and expects to receive between $7.5 billion and $9.5 billion through 2034 from the Act.
Capital Allocation: In 2024, TI returned $5.72 billion to shareholders, including $4.80 billion in dividends and $929 million in share repurchases. As of December 31, 2024, $20.26 billion remained available under share repurchase authorizations.
Risks and Contingencies:
- Market Cyclicality: The semiconductor industry is cyclical; demand fluctuations can lead to inventory adjustments and margin pressure.
- Geopolitical & Trade: Operations in over 30 countries expose TI to geopolitical tensions, trade restrictions, and currency fluctuations. Approximately 20% of revenue comes from end customers headquartered in China.
- Manufacturing Execution: Risks associated with the timely implementation of new manufacturing technologies and the realization of expected returns on significant capital investments.
- Competition: Intense competition from global suppliers, including emerging companies in Asia, may pressure pricing and margins.
Key Facts for Investor Verification
- Capacity Expansion Progress: Verify the ramp-up status of the 300mm wafer fabrication facilities (RFAB2, LFAB1, SM1, SM2, LFAB2) and whether they are meeting production targets to offset fixed cost increases.
- CHIPS Act Funding: Monitor the receipt of direct funding (up to $1.6 billion) and the utilization of investment tax credits under the CHIPS and Science Act, which significantly impacts cash flow and asset carrying values.
- Inventory Levels: Assess the trend in inventory days (currently 241) to ensure the build-ahead strategy does not lead to obsolescence or write-downs if demand softens further.
- Debt Servicing: Review the impact of increased debt levels ($13.6 billion total) on interest coverage ratios, given the higher interest expense environment.
- China Exposure: Evaluate the impact of ongoing geopolitical tensions on the 20% of revenue derived from China-based end customers.